Table 3 Drug-Likeness properties of compounds 2–5 and 8–11
Compound | MW | nRot | HBA | HBD | TPSA | MLog P | Lipinski rule violation | Synthetic accessibility |
|---|---|---|---|---|---|---|---|---|
2 | 317.36 | 5 | 4 | 2 | 88.58 | 1.13 | 0 | 2.75 |
3 | 413.88 | 6 | 4 | 2 | 88.58 | 2.86 | 0 | 3.10 |
4 | 409.46 | 7 | 5 | 2 | 97.81 | 2.06 | 0 | 3.13 |
5 | 393.46 | 6 | 4 | 2 | 88.58 | 2.60 | 0 | 3.12 |
88 | 414.48 | 5 | 3 | 1 | 92.00 | 3.44 | 0 | 3.71 |
9 | 448.92 | 5 | 3 | 1 | 92.00 | 3.91 | 0 | 3.68 |
10 | 265.27 | 2 | 3 | 1 | 63.82 | 2.31 | 0 | 2.55 |
11 | 387.36 | 4 | 5 | 0 | 70.03 | 3.90 | 0 | 3.19 |